Elucidation of the molecular mechanism underlying tumor-selective replication of the oncolytic adenovirus mutant ONYX-015

By Ries Stefan J  

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 763-766

Future Medicine

Access to resources Recommend Favorite

FAK and p53 Protein Interactions

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 7, 2011-09 ,pp. : 617-619

Bentham Science Publishers

Access to resources Recommend Favorite

Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma

By                  

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 223-231

Spandidos Publications

Access to resources Recommend Favorite

In VivoStudies of Adenovirus-Based p53 Gene Therapy for Ovarian Cancer

By von Gruenigen V.E.   Santoso J.T.   Coleman R.L.   Muller C.Y.   Miller D.S.   Mathis J.M.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

Adenovirus-Based p53 Gene Therapy in Ovarian Cancer

By Santoso J.T.   Tang D-C.   Lane S.B.   Hung J.   Reed D.J.   Muller C.Y.   Carbone D.P.   Lucci II. J.A.   Scott Miller D.   Mathis M.J.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite